RFG
NVO

REAP Financial Group’s Novo Nordisk NVO Stock Holding History

REAP Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-155
Closed -$5.7K – 571
2026
Q1 		$5.7K Buy
+155
New +$7.34K ﹤0.01% 433
2025
Q1 		– Sell
-134
Closed -$11.5K – 643
2024
Q4 		$11.5K Buy
134
+1
+0.8% +$108 ﹤0.01% 352
2024
Q3 		$15.9K Hold
133
– – ﹤0.01% 294
2024
Q2 		$19K Buy
133
+1
+0.8% +$133 0.01% 251
2024
Q1 		$17K Hold
132
– – ﹤0.01% 299
2023
Q4 		$13.7K Buy
+132
New +$13.1K ﹤0.01% 364

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

REAP Financial Group's NVO Position: Q2 2026 in Review

REAP Financial Group sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 155 shares — an estimated $5.7K sold.

REAP Financial Group first reported a position in NVO in Q4 2023 and held it in 6 quarters. The position peaked at $19K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • REAP Financial Group reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • REAP Financial Group sold 155 Novo Nordisk shares in Q2 2026, an estimated $5.7K.
  • REAP Financial Group first reported a position in Novo Nordisk in Q4 2023 and held it in 6 quarters.
  • REAP Financial Group's Novo Nordisk position peaked at $19K in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.